Lausanne, Switzerland and Seville, Spain, May 24, 2018 / B3C newswire / -- Lunaphore Technologies SA, a next generation tissue diagnostics company, and Vitro SA, a manufacturer in the field of Pathology and Biomedical Research, announce today a …
Partnership will enable women in Singapore, Malaysia, Vietnam, Brunei and Myanmar to access the benefits of MammaPrint® and BluePrint® to personalize treatment management decisions for early breast cancer Irvine, CA, USA and Amsterdam, the Netherlands , …
San Ramon, CA, USA, May 23, 2018 / B3C newswire / -- rfxcel Corporation, a technically certified Gateway Provider for the European Medicines Verification Organisation (EMVO) announced today that it will pay the cost of statutory fees payable to EMVO* for …
Oxford, UK, May 23, 2018 / B3C newswire / -- Orbit Discovery Ltd, an Oxford, UK-based biotech company developing an industry-leading peptide identification and optimisation platform, today announced the closing of a £6.9M Series A Financing. The round was …
Burton-On-Trent, England, May 22, 2018 / B3C newswire / -- Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, has partnered with Mitsubishi Tanabe Pharma Corporation (‘MTPC’), to initiate a Managed Access Program ( …
Deqing, China, May 17, 2018 / B3C newswire / -- Shuwen Biotech, a leading provider of innovative diagnostic products and medical diagnostic services, announced that studies based on its proprietary high-sensitivity CODAR-ARMS PCR liquid biopsy technology …
TheraT®-induced CD8+ T cells are resistant to select checkpoint inhibitors, unlike CD8+ T cells induced by other vectors such as recombinant Listeria TheraT®-induced CD8+ T cells are qualitatively differentiated from CD8+ T cells induced by other vector …
Irvine, CA, USA and Amsterdam, the Netherlands, May 15, 2018 / B3C newswire / -- Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announce that Unicancer, a hospital group entirely devoted to fighting cancer, has …
Hannover, Germany, May 14, 2018 / B3C newswire / -- Ophthalmic medical device company Implandata Ophthalmic Products GmbH (Implandata) announced that the company accomplished a first closing of its Series C funding round. The company was able to raise a …
Oxford, UK, May 14, 2018 / B3C newswire / -- Emergex Vaccines Holding Limited (‘Emergex’), a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, today announces that Innovate UK, the UK’s innovation …
Uppsala, Sweden, May 10, 2018 / B3C newswire / -- Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, is pleased to announce the launch of a new unique UV Monitor Kit which can be …
Basel, Switzerland, May 08, 2018 / B3C newswire / -- Celonic AG, the Swiss biologics contract development and manufacturing organization, has appointed Soenke Brunswieck as Vice President Cell & Gene Therapy to establish Celonic`s new portfolio of CDMO …
Cambridge, UK and Deqing, China, May 07, 2018 / B3C newswire / -- Abcam, a global leader in the supply of life science research tools, today signed a Memorandum of Understanding (MoU) with Shuwen Biotech, a leading player in the development and …
Basel, Switzerland, May 04, 2018 / B3C newswire / -- On the occasion of its 20th anniversary, the Swiss Biotech Association launches Swiss Biotech Success Stories in recognition of the industry’s many accomplishments. Swiss Biotech Success Stories will …
Cambridge, United States, May 03, 2018 / B3C newswire / -- Haselmeier, a Swiss-based developer and manufacturer of innovative self-injection devices, and Common Sensing, a Cambridge-based smart injector monitoring and support solutions company, today …
Orchard’s fourth Rare Pediatric Disease Designation for autologous ex vivo gene therapy. Boston, USA and London, UK, May 03, 2018 / B3C newswire / -- Orchard Therapeutics, a leading commercial stage company dedicated to transforming the lives of patients …
Transaction increases profit potential of aducanumab for Biogen and provides near-term capital to Neurimmune Cambridge, Mass., USA and Schlieren/Zurich, Switzerland, May 01, 2018 / B3C newswire / -- Biogen (Nasdaq: BIIB) and Neurimmune announced today that …
Schlieren / Zurich, Switzerland, April 26, 2018 / B3C newswire / -- Neurimmune, a global leader in the discovery and development of human-derived monoclonal antibodies, today announced that it has appointed Dr. Fabian Buller to the newly created position …
Boston, USA and London, UK, April 24, 2018 / B3C newswire / -- Orchard Therapeutics, a leading commercial and clinical-stage company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today announced the …
Data presented at 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Madrid, Spain DNAe’s LiDia® BSI method accurately detected pathogen and antibiotic resistance in samples collected from patients receiving antibiotic …
